Phytochem Remedies IPO Details
The key details of Phytochem Remedies’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹38.22 Cr |
| Price Range | ₹98 |
| Retail Quota | 50% |
| QIB Quota | -- |
| NII Quota | 50% |
| Employee Discount | -- |
| Listing at | BSE |
| Minimum Quantity | 2,400 |
| Investment (cut-off price) | ₹2,35,200 |
| Pre IPO Promotor Holding | 100.00% |
| Post IPO Promotor Holding | 66.88% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Phytochem Remedies IPO Timelines
The IPO process for Phytochem Remedies includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
18/12/2025
Start Date22/12/2025
End Date24/12/2025
Refund Initiation24/12/2025
Credit of Shares to Demat AcUpdate soon
Listing DatePhytochem Remedies IPO Lot Size
The Phytochem Remedies IPO has a fixed lot size of 1,200 shares, at a fixed price band of ₹98 per share. For retail investors, the minimum and maximum application is 2,400 shares (2 lots) amounting to ₹2,35,200. For HNI investors, the minimum application is 3,600 shares (3 lots) worth ₹3,52,800.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2400 | ₹2,35,200 |
| Retail Maximum | 2 | 2400 | ₹2,35,200 |
| HNI Minimum | 3 | 3600 | ₹3,52,800 |
Phytochem Remedies IPO Subscription Status
The subscription status for Phytochem Remedies IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| -- | 0.31x | 0.83x | -- | 0.57x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹ | ₹ | ₹ | ₹ |
Phytochem Remedies IPO Company Financials
Phytochem Remedies reports robust performance in FY2026 September with Total Income of ₹25.01 crores, managing expenses at ₹19.81 crores, and achieving a strong PAT (Profit After Tax) of ₹3.75 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2023 | ₹20.83 | ₹19.68 | ₹0.82 |
| FY 2024 | ₹32.90 | ₹29.76 | ₹2.31 |
| FY 2025 | ₹36.81 | ₹30.75 | ₹4.48 |
| FY 2026 (6 M) | ₹25.01 | ₹19.81 | ₹3.75 |
About Company
Incorporated in 2002, Phytochem Remedies (India) Limited is a Jammu-based manufacturer of corrugated boxes and corrugated board solutions. The company primarily caters to industries such as food and beverages, FMCG, pesticides, pharmaceuticals, and automotive. As of September 30, 2025, the company employed a total of 51 people.
Phytochem Remedies operates through two manufacturing units located at Bari Brahmana, Jammu. Unit 1 has a total allocated area of 43,360 square feet, of which approximately 12,000 square feet is currently utilized, while Unit 2 has an allocated area of 1,73,440 square feet with around 55,000 square feet in use. The company’s product portfolio includes corrugated boxes in 3-ply, 5-ply, and 7-ply variants, printed corrugated boxes, corrugated rolls, and corrugated pads and sheets.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2002 | Packaging | Niranjan Surana |
Know Before Investing
Phytochem Remedies IPO Strengths
- Phytochem Remedies (India) is a Jammu-based manufacturer of corrugated boxes and related packaging solutions, serving pharma, FMCG and other sectors with customised boxes and printed packaging.
- Full automation implemented around 2022 has enhanced productivity, supporting higher margins and profitability at current utilisation levels.
- Rising pharma, e‑commerce and FMCG volumes increase demand for corrugated and printed packaging, providing sectoral tailwinds.
- Planned prepayment of borrowings should reduce interest costs and improve financial flexibility going forward.
- Revenue grew about 12% from ₹32.90 crore in FY24 to ₹36.81 crore in FY25, while PAT almost doubled by ~94% from ₹2.31 crore to ₹4.48 crore, indicating strong operating leverage.
Phytochem Remedies IPO Risks
- Despite the “Phytochem Remedies” branding, the company is essentially a corrugated packaging manufacturer and not a pharma products maker, which may confuse investors about the core business.
- Corrugated packaging is a fragmented space with thousands of small and mid‑sized players, limiting pricing power and exposing margins to price competition.
- Profitability depends heavily on kraft paper and paperboard prices; any spike not fully passed through to customers could compress the currently elevated margins.
- Manufacturing is concentrated in Jammu, creating geographic risk from local disruptions, policy changes or logistics constraints.
- The company has a relatively short track record post‑automation and at current margin levels, making long‑term performance less predictable.
Swot Analysis for Phytochem Remedies IPO
Strengths
Focused Packaging Player, Diversified Customer Industries, Consistent Financial Growth
Weaknesses
High Customer Concentration, History of Negative Cash Flows, Geographic Concentration
Opportunities
Rising Packaging Demand, Sustainability Tailwinds, Deeper Client Penetration
Threats
Raw Material Price Volatility, Client Insolvency Risk, Regulatory & Environmental Changes
Company Details
Phytochem Remedies (India) Ltd.
220, Ashok Nagar Main Road, Udaipur City, Girwa, Udaipur, Rajasthan, 313001
Phone: +91 294 4577549
Email: cs@phytochem.co.in
Website: http://www.phytochem.co.in/
IPO Registar Details
Bigshare Services Pvt. Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
FAQs
The key objectives of Phytochem Remedies SME IPO are:
- Funding capital expenditure requirements for the purchase of equipment/machineries
- Funding capital expenditure requirements towards civil construction
- Repayment/pre-payment, in full or in part, of certain borrowings availed by the Company
- General Corporate Purposes
Mefcom Capital Markets Ltd. is the book-running lead managers for the Phytochem Remedies IPO.
Phytochem Remedies IPO offers growth potential backed by India’s packaging demand growing around 11% CAGR, rising pharma and FMCG usage, and capacity expansion. Fresh issue proceeds of about ₹38.22 crore for machinery, civil works, and debt reduction should lift utilisation, volumes, and margins as operations scale efficiently.
The issue price for the Phytochem Remedies IPO is set to ₹98 per share.
To invest in two lot of Phytochem Remedies IPO, you need ₹2,35,200 at the fixed price band (₹98 per share) for a lot size of 2400 shares.
Phytochem Remedies IPO shares are scheduled to be listed on the Bombay Stock Exchange (BSE) on December 26, 2025.
Refund/unblocking of funds for Phytochem Remedies IPO will begin on December 24, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Phytochem Remedies IPO shares on listing day (December 26, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.